Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for C7532. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
11
Median % of Medicare
80%
Rate range
$3,286.27 - $6,308.81
C7532 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $5,993.37* | 95% | -- | 2026 |
| Arizona | $3,434.42 | 54.4% | -- | 2026 |
| Idaho | $5,366.05 | 85.1% | Not required | 2023 |
| Kentucky | $6,158.34 | 97.6% | -- | 2026 |
| Massachusetts | $4,495.47 | 71.3% | -- | 2026 |
| Michigan | $3,299.51 | 52.3% | -- | 2026 |
| Missouri | $5,602.42* | 88.8% | Not required | 2026 |
| Montana | $6,308.81 | 100% | -- | 2026 |
| North Dakota | $3,630.35 | 57.5% | Not required | 2026 |
| Oregon | $5,047.05* | 80% | -- | 2026 |
| Utah | $3,286.27* | 52.1% | Not required | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 33 codes from C7502 to C7565 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for C7532?
11 state Medicaid programs publish a fee-for-service rate for C7532 (transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation), ranging from $3,286.27 in Utah to $6,308.81 in Montana, with a median of 80% of the national Medicare amount. The full table on this page lists every publishing state's current rate.
Which state pays the most for C7532?
Montana publishes the highest Medicaid rate for C7532 at $6,308.81 (100% of the national Medicare amount). Utah publishes the lowest at $3,286.27.
Does C7532 require prior authorization under Medicaid?
No publishing state flags C7532 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.